Lv6
2935 积分 2021-04-30 加入
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial
7天前
已完结
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study
7天前
已完结
Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial
7天前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
7天前
已完结
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
7天前
已完结
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
7天前
已完结
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
7天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
7天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
8天前
已完结
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management
14天前
已完结
皖公网安备34019202002308
